About the NIH Clinical Center

NIH Clinical Trials Search Page

Return to NIH Listings Menu

Non-NIH Trial Listings

Research centers specializing in this illness area

Additional resources in this illness area

NIH Studies: Psychiatry/Psychology

Below is a listing of government-funded clinical trials in Psychiatry/Psychology, being conducted by the various National Institutes of Health at the Warren Grant Magnuson Clinical Center in Bethesda, MD.

Click on a study summary to view the study description and contact information directly from the NIH's web site.

[*]The Antidepressant Efficacy of the Anticholinergic Scopolamine

[*]The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers

[*]Double Blind Trial of DC Polarization in FTD

[*]PET Imaging of Dopamine D2 Receptors and Extracellular Dopamine with (18F)Fallypride, D-amphetamine, and Alpha-Methyl-Para-Tyrosine in Healthy Subjects

[*]Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

[*]Evaluation of SubstanceP Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors with [18F] SPA-RQ

[*]Psychopharmacology Investigations of Fear Conditioning in Humans

[*]Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal

[*]Assessment and Treatment of People with Alcohol Drinking Problems

[*]Adolescence, Puberty, and Emotion Regulation: An fMRI Study

[*]The Evaluation of Patients with Autism Spectrum Disorders and Healthy Volunteers

[*]Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

[*]An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects

[*]Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

[*]The treatment of Menstrually-Related Mood Disorders with Extended Versus Interrupted Oral Contraceptives

[*]Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 40 Drinks Per Week

[*]Association Between Adenosine Receptor Gene Polymorphisms and Psychiological Responses to Caffeine in Subjects with Panic Disorder and Health Controls

[*]Treatment of Winter Depression with Pharmacological Suppression of Melatonin Secretion

[*]Fluoxetine's Effects on Attention and emotional memory in Anxious and Depressed Youth

[*]Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation

[*]An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder

[*]An Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of BPD

[*]An Endocrine Model For Postpartum Mood Disorders

[*]The Phenomenology and Biophysiology of Climacteric and Menopause-Related Mood and Behavioral Disorders

[*]Biological Markers in Childhood Psychiatric Disorders

[*]A Longitudinal Investigation of Siblings of Schizophrenic and Manic-Depressive Patients

[*]Candidate Genes in Obsessive-Compulsive Disorder

[*]Biochemical Studies of Patients and Normal Volunteers

[*]Non-Parametric and Parametric Linkage Studies of Stuttering

[*]Dopamine Receptor Imaging in Mood Disorders

[*]Effects of Arousal and Stress on Classical Conditioning

[*]Serotonin 1A Receptor Imaging and Benzodiazepine Receptor Imaging in Panic Disorder and Posttraumatic Stress Disorder

[*]Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Nonalcoholics

[*]Adolescent Medial Temporal Lobe Function in Health and Illness

[*]Reward-Related Processes and Brain Function

[*]Severe Mood and Behavioral Dysregulation in Children: Pathophysiology and Treatment with Lithium

[*]A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control

[*]A Double-Blind Study Examining The Efficacy Of The Protein Kinase C Inhibitor Tamoxifen In The Treatment Of Acute Mania

[*]Screening Evaluation for NIAAA Protocols

[*]Serotonin1A Receptor Imaging In Mood Disorders

[*]Investigating the Role of Norepinephrine in Emotional Processing through Alpha-2 Adrenergic Receptor Modulation

[*]NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence

[*]A Clinical and Immunological Investigation of Regression in Autism

[*]Timing of Voluntary Movement in Patients with Schizophrenia Using EEG and Surface EMG

[*]The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

[*]Effect of Alprazolam on Fear-Potentiated Startle in Humans

[*]Fear Conditioning Using Computer-Generated Virtual Reality

[*]Changes in Activation Patterns in the Ventro-Medial Prefrontal Cortex of Healthy Adolescents During the Imagination and Observation of Aggressive Behavior

[*]An Investigation of the Antidepressant Efficacy and Safety of an AMPAkine (Org 24448) in Major Depressive Disorder, A Double-Blind, Placebo-Controlled, Randomized Study

[*]Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging

[*]Brain Networks Responsible for Self-Agency: An fMRI study

[*]Neuropsychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure

[*]A Screening Protocol to Evaluate Women with Postpartum-Related Mood and Behavioral Disorders

[*]Inpatient Evaluation of Neuropsychiatric Patients

[*]Anatomic MRI Brain Imaging of White Matter in Children

[*]The Effects of Fluoxetine on Measures of Domestic Violence

[*]Muscarinic Cholinergic Receptor Imaging in Depression

[*]The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders

[*]Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

[*]Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning

[*]Bone Mineral Density in Patients with Major Depression with Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function

[*]The Psychobiology of Temperament: An fMRI Study

[*]An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent

[*]Clinical Molecular and Biochemical Characterization of Familial Presenile Dementia with Neuronal Inclusion Bodies

[*]The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder

[*]PET Imaging of Brain 5-HT1A Receptors Using [11C](-)-RWAY

[*]Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype

[*]Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression

[*]The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness

[*]Treatment of Patients with Alcoholism and Attention Deficit Disorder

[*]5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement

[*]The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women with Perimenopausal Depression

[*]Psychobiological Mechanisms of Resilience to Trauma

[*]Randomized, Double-Blinded, Placebo Controlled Study Of The Effects Of Tolcapone On Cognitive Function In Patients With Schizophrenia And Normal Controls Based On COMT Genotype

[*]Family Study of Affective and Anxiety Spectrum Disorders

[*]Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

[*]Effect of D-Cycloserine on the Treatment in Social Phobia

[*]Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations

[*]Predictability and Aversive Expectancies in Anxiety Disorders

[*]Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study

[*]Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging

[*]Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients with Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp

[*]Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function

[*]PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome

[*]The Development of Categorization

[*]Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients

[*]The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)

[*]Influence of Age and Gender on Alcohol Metabolism and Acute Responses

[*]Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Motor Reactivity

[*]Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects

[*]The Evaluation and Follow-up of Patients with Obsessive-Compulsive Disorder and OC Spectrum Disorders

[*]The Treatment of Menstrually-Related Mood Disorders with Gonadal Steroid Replacement: An Endocrine Clamp Model

[*]An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression

[*]fMRI Investigation of Explicit Cure and Contexual Fear

[*]Screening Protocol for Childhood Onset Psychotic Disorders

[*]Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome

[*]Neurocardiac Control in Major Depression

Last updated: September 15, 2006 at 4:30:37 PM


Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA